chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle pain on upper extemedies  Hip,back , pain on both arms  Left had has been swollen for 2 days  After one week of vaccination
Patient was given undiluted pediatric dose .2 ml Patient was contacted.  No side effects noted. Patient scheduled for full booster in 8 weeks, per CDC guidelines
SEVERE MIGRAINE HEADACHE; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included migraines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 21-JUN-2021) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid/caffeine/paracetamol/salicylamide for migraines. On 29-APR-2021, the subject experienced severe migraine headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe migraine headache was not reported. This report was non-serious.
Body aches; fever; chills; headache; This is a spontaneous report from a contactable healthcare professional. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 16:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 21Mar2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Apr2021 at 01:00, the patient experienced body aches, fever, chills and headache. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events body aches, fever, chills and headache were not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided          Reporter did not allow further contact
her cycle came on so painful and so heavy/ pain was so severe; her cycle came on so painful and so heavy and when she stood up it poured out of her which was unusual; she was throwing up and was crying; she was throwing up and was crying; her cycle came on so fierce and was so heavy and so painful that she could not move; she was sweating profusely; sore arm; This is a spontaneous report from a contactable consumer (patient reporting for herself). A 48-year-old female patient received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in the left arm, on 07Oct2021 (batch/lot number: FE359 and expiration date: 28Feb2022) at the age of 48 years old, as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history included very regular menstrual cycle. Patient can tell what day her cycle is supposed to come and has never had intermittent bleeding even when she was pregnant with her children. There is no family medical history relevant to events reported. There were no concomitant medications and no prior vaccinations (within 4 weeks). Patient reported that when she got the first vaccine on 07Oct2021, her cycle was not due until 14Oct2021 or around there. On 07Oct2021 she had a sore arm. When her cycle came on 15Oct2021, when it actually came, she was out of town and couldn't leave her hotel because her cycle came on so painful and so heavy. When she stood up, it poured out of her which was unusual. She did not associate it with the shot which occurred on 07Oct2021. She thought it was a bad cycle and the pain was so severe, she was throwing up and was crying and nothing like that had happened to her before and she never associated it with the shot because it did not click with her when her cycle came and was supposed to come. Her cycle came on so fierce and was so heavy and so painful that she could not move and to throw up from her cycle, she was sweating profusely, started crying, and the pain was so severe. She thought about going to the Emergency room, but she never went to the doctor for her cycle ever. The events did not require a visit to the Emergency Room or a Physician Office No relevant tests were performed. The outcome of the events was unknown.  Follow-up attempts completed. No further information is expected.
Patient awoke around 11:00am on 11/20/22 to find a painful rash mostly on the palmar sides of both hands.  There is no rash at any other location.  The rash is described as small, interrupted round, raised, red spots of multiple sizes and painful, no open wounds or blisters.  Treatment prescribed is triamcinolone acetonide topical cream 0.5%, Prednisone 20mg two tablets orally once daily for 3 days and mupirocin 2% ointment.
pt recv vax;devel fever & a rash w/ about 15-18 lesions on abd;felt poorly for 3 days;
2/4/2021 - Vaccine 2/26/2021 - Left Ankle surgery 4/9/2021 - Left leg swelling 4/22/2021 - Ultrasound found clots in left leg from groin to ankle
Arm  pain..site of injection; Itchiness at site of injection; Bullseye shaped rash around injection site which was diffuse and red; Itchy eyes; Soreness around injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (Arm  pain..site of injection), EYE PRURITUS (Itchy eyes), VACCINATION SITE PAIN (Soreness around injection site), VACCINATION SITE PRURITUS (Itchiness at site of injection) and INJECTION SITE RASH (Bullseye shaped rash around injection site which was diffuse and red) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Hay fever and Allergy (tuberculin test).    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced EYE PRURITUS (Itchy eyes) and VACCINATION SITE PAIN (Soreness around injection site). On 31-Dec-2020, the patient experienced VACCINATION SITE PAIN (Arm  pain..site of injection), VACCINATION SITE PRURITUS (Itchiness at site of injection) and INJECTION SITE RASH (Bullseye shaped rash around injection site which was diffuse and red). On 26-Dec-2020, EYE PRURITUS (Itchy eyes) and VACCINATION SITE PAIN (Soreness around injection site) had resolved. On 04-Jan-2021, VACCINATION SITE PRURITUS (Itchiness at site of injection) and INJECTION SITE RASH (Bullseye shaped rash around injection site which was diffuse and red) had resolved. At the time of the report, VACCINATION SITE PAIN (Arm  pain.site of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment of events was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Patient declined follow-up. No new information.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
muscle aches; nausea; vomiting; weakness; chills; Diarrhea; Joint pain; It scared me that I was so sick.; Slight headache like a little pressure on her head / Horrible headache; This is a spontaneous report from a contactable consumer (patient). A 75-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, Lot number EL9262 (the patient was not sure of the second letter), via an unspecified route of administration in left arm on 23Jan2021 at 16:15 at single dose for COVID-19 immunization. Medical history included sinus infection. The patient was not pregnant at the time of vaccination. Facility where the COVID-19 vaccine was administered was Hospital. The patient has not been tested for COVID-19 since the vaccination. Concomitant medication included amoxicillin, clavulanic acid (AUGMENTINE) for sinus infection and pravastatin. The patient stated that when she went home after vaccination, she had a slight headache, like a little pressure on her head when she went to bed but that was supposed to be normal. So, she went to sleep and the next morning she woke up and she had every single side effects: the nausea was horrible, she must have thrown up 15 times, she had diarrhea and joint pain. She did not think she had any fever but she did had chills and muscle pain, weakness and had horrible headache. The events onset date was reported as 24Jan2021 at 12:00 AM (except for headache which started on 23Jan2021). No treatment was administered for these events. The patient stated that it scared her that she was so sick. All the reported events were assessed as non-serious. The patient reported that 3 days later she was still feeling very weak. At the time of the report the events headache, muscle aches, nausea, vomiting and chills had recovered with sequelae, the event weakness had not yet resolved, whereas the outcome of the events diarrhea, joint pain and sickness was unknown.
Within 5 minutes of shot, pt complained of chest and back pain. There was also some shortness of breath. Symptoms subsided after patient was walked to a chair and comforted by family and staff.
This spontaneous report was received from a pharmacist refers to a patient of unknown age. The medical history of the patient was unknown. It was reported that on an unknown date, the pharmacist had used two partial sterile diluents (lot # J010232, expiry date was 31-OCT-2015) vials to equal 0.65 ml in order to reconstitute one ZOSTAVAX (lot number and expiry date not provided). The concomitant medications were not reported. No adverse events were reported. Product quality complaint was involved. Additional information has been requested.
11/22/2021 -# 1 vaccine administered. 01/05/2022 - # 2 vaccine administered. 01/09/2022 - Persistent gum bleeding noted. 01/11/2022 - CBC showed severe pancytopenia. 01/11/2022 - admitted to community hospital, received 1 unit whole blood transfusion; initial rapid Covid antigen test was positive but RT-PCR test was negative x2. 1/14/2022 - transferred to higher level hospital; admitted to ICU for neutropenic fever and treated for pneumonia; continues to bleed - w/ hematuria; received 2 units whole and 4 FFP's. RT PCR test for Covid was negative. Currently remains in ICU requiring more blood product transfusion. Clinically looks like aplastic anemia and bone marrow failure.
I have a large red circle appear on my arm about 2 inches below the injection site of vaccine. Circle is about 4 inches across & slightly warm to the touch.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's relevant medical history and concomitant medication were not reported. On an unknown date in 2015 (reported as since 14-MAY-2015, which was the date the excursion occurred), the patient was vaccinated with a dose of VARIVAX (Merck) (dose, route of administration, lot# and expiration date were not reported), which underwent supported temperature excursions. No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Started with swelling of R arm then progressed to Rash on the B/L arms and across the lower back.
After receiving H1N1 vaccine injection in left arm, patient complained of shooting pain down to fingers in left arm and reported a bad headache. Patient observed by school nurse and given Tylenol. Symptoms resolved and child returned to class.
Patient came into the pharmacy on 6/11/2022 and wanted to get a 2nd Pfizer booster.  A pharmacist working saw that the patient got 3 doses of Pfizer (12/10/21, 2/3/22, and 2/24/22) and did not give her the 2nd booster because it was too early (4 months has not passed yet since 2/24/22). The pharmacist also noted that the timeline between the 2nd shot and the 1st booster was 21 days apart. We left a message for the patient to contact us back to discuss if there were any adverse effects on and after 2/24/22 due to the short interval in between shots .
PFIZER REQUIRES 1.8ML OF DILUENT TO BE USED BEFORE ADMINISTERING THE VACCINE.  ONLY 0.8ML WAS USED, CAUSING ONLY 4 FILL DOSES TO BE IN THE VIAL.  UPON GOING TO DRAW UP THE 5TH DOSE FOR THE DAY, I NOTICED THERE WAS NOT ENOUGHT LIQUID IN THE VIAL.
Narrative:  COVID infection following COVID vaccine series and after previous COVID infection 09/02, Pfizer, dose #1 09/23, Pfizer, dose #2 07/08 COVID swab, detected 12/23 COVID swab, result: detected 12/23 pt cc: myalgias, headache, fatigue exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending
Rash, fever, pruritus  - Information has been received from a consumer concerning her daughter who in approximately April 1999 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  approximately 10 days post-vaccination the patient had a fever and broke out in a itch/rash all over her body.  The patient sought unspecified medical attention.  The patient's sistem (WAES #00070872) had a similar experienced following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Additional information has been requested.
Itchy urticaria all over my body with strong muscle and joint pain in both arms, barely could use them, started 1 week after i got my third Moderna vaccination (only half amount). Arm pain diappeared in 4 days but hives still active for 5 weeks now. I am taking antihistamin pills 1 (Cetirizin) in the morning 1 (Fexgen) in the evening with Monteculast.
allergist reports that pt exp an urticarial rash 7-8 days p/vax; vaccinating MD reports pt @ 6mos recvd vax on 1JUN93; 8JUN devel urticaria; MD visit on 9JUn rx'd w/DPH IV steroids; urticaria resolved;
pt recv vax 5SEP97 & swelling @ site & wheezing on 7SEP97;used albuterol nebulizer;pt seen in clinic on 11SEP97;wheezing worse;cont albuterol nebulizer;start steroids;
Generalized pain in various limbs suchas arms and legs. Pain started on 07/03/02 and continues now.
Pt c/o red/swollen area with itching to LMT where DTPA injection given 4 x 4 area
Onset of chills and pain at site. Redness and swelling at injection site. Approximately 4cm x 10cm. Treated with Keflex.
This spontaneous report was received from physician, via field representative, referring a 21 year old female patient. The patient's medical history, concomitant medication, allergies and drug reactions were not reported. In April 2017, the patient was vaccinated GARDASIL 9 injection, a single dose of 0.5 ml, intramuscular for prevention of HPV (anatomical injection site, lot # and expiration date were not provided). In May 2017, the patient developed a cyst on her right ovary. The patient sought medical attention from a physician, and subsequently she was hospitalized, on an unspecified date in 2017, for the surgical removal of the ovarian cyst in July 2017. It was unknown if laboratory test were performed to the patient. At the time of this report, the patient recovered from the adverse event. The causality assessment between the GARDASIL 9 and the adverse event was not provided. Upon internal review, the event ovarian cyst was determined to be medically significant as an ovarian cystectomy was performed.
Mild to moderate chest pressure, directly center of chest, under sternum. Woke up with all other normal side effects the day after the second dose, plus had this chest pressure. Is the only side effect still lingering after 7 days now. Not causing shortness of breath when resting, but does when doing previously normal activities.
This spontaneous report was received from a registered nurse referring to a 47 year old female patient. The patient's pertinent medical history, concurrent conditions, concomitant therapies and past drug reactions/allergies were not reported. On 15-MAY-2017, the patient was vaccinated with a dose of  PROQUAD lot # M038861 with expiration date: 13-MAR-2018 (strength, route, and anatomical location were not reported) for prophylaxis. On the same date, the patient was also vaccinated with a dose of VARIVAX lot # M046005 with expiration date: 18-NOV-2018. Other concomitant therapy included the sterile diluent. The reporting nurse stated that the dose of PROQUAD was inadvertently given instead of an intended dose of M-M-R II; this product packaging confusion occurred due to the "boxes looked the same". Furthermore, the reporter stated that the administration of PROQUAD was outside of age range parameters. No adverse effects were reported.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown demographics. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unspecified dates beginning in December 2015, the patients were vaccinated with doses of improperly stored ROTATEQ orally (lot # L006184, expiration date: 13-DEC-2016, lot # L027067, expiration date: 06-APR-2017 and lot # L029617, expiration date: 19-MAY-2017; dose was not provided). The vaccine was exposed to temperature of 32 degrees Fahrenheit for 30 days. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Trouble breathing, 5 days in hospital; Shocks in chest; Fatigue; Itchiness on back; This serious case was reported by a consumer via call center representative and described the occurrence of difficulty breathing in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included VARICELLA ZOSTER VACCINE RGE (SHINGRIX) for prophylaxis.   Concurrent medical conditions included emphysema and chronic obstructive pulmonary disease.   In OCT-2022, the patient received the 2nd dose of Shingrix (left arm). In AUG-2022, the patient received the 1st dose of SHINGRIX (left arm). In OCT-2022, 2 weeks after receiving Shingrix, the patient experienced shock (Verbatim: Shocks in chest) (serious criteria hospitalization and GSK medically significant), fatigue (Verbatim: Fatigue) (serious criteria hospitalization) and pruritus (Verbatim: Itchiness on back) (serious criteria hospitalization). On an unknown date, the patient experienced difficulty breathing (Verbatim: Trouble breathing, 5 days in hospital) (serious criteria hospitalization). The outcome of the difficulty breathing was not reported and the outcome of the shock, fatigue and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the difficulty breathing, shock, fatigue and pruritus to be related to Shingrix.     It was unknown if the company considered the difficulty breathing, shock, fatigue and pruritus to be related to Shingrix.   Additional Information: GSK receipt date: 8-Mar-2023 The patient stated that about 2 to 3 weeks after getting the second vaccine, he started experiencing fatigue, itchiness on the right side of his back, and shocks in his chest on the right side.   The patient stated that he was still having these symptoms, but they are better then when they first started.   The patient did not  had lot or expiry dates for the vaccines.  The patient also mentioned while on the call that he was in the hospital about a month ago for 5 days due to having trouble breathing related to his chronic obstructive pulmonary disease and emphysema. The reporter consented to follow-up.
Approximately 24 hours after receiving the shot i began to feel ?off? by the night of the 10th I became tired and experienced mild body ache and a fever that topped out at 100.9 degrees I continued to hydrate and take ibuprofen and rested by the evening of April 11th I began to feel better and by April 12th I felt back to normal.
No adverse events at this time - Patient was given 0.6mL of vaccine instead of 0.3mL
Fever, chills, severe body aches and massive headache, and pain at site of injection all started  about 4 hours after vaccine which lasted  about36 hrs.  After the fever subsided and body aches lessened, a mild yet painful rash  appeared on the arm 1.5 inches from injection site.  Occasionally, I felt momentary sharp nerve pain on various parts of my body including areas below left breast, at the junction  between thigh and abdomen, below left nostril, right tricep, and various locations on back.
Extreme soreness and redness at injection site, followed by fever (up to 101*) for next 36 hours.  Unusual muscle and joint pain and fatigue. Redness at injection site spread to entire upper arm and lessened somewhat before dissipating around 6 days later.
is here today for ED follow-up on A-fib. Patient stated she is not taking Eliquis.    She had no side effects from her first COVID-19 vaccine. After the 2nd one she had muscle aches, headache, freezing cold, and "weird", and felt really badly then at 9:30 PM, 32 hrs after the 2nd vaccine dose she felt the a-fib started. She had not been in a-fib in many years. Cardiology had already recommended eliquis but she was holding off. She had diltiazem from 2017 that she tried but with out relief. They rate controlled her but she remained in a-fib, started eliquis, and she went home. For 2.5 weeks she had headache and chest pain, other muscle pain, felt horrible, until she stopped the Eliquis.  Since stopping the Eliquis, she still has occasional mild chest pain, and headache, and flushing.   Her current chest pain is left chest, not radiating. The quality varies, stabbing pain in a very small location at times, may be associated with eating.   She did have a stress test years ago and was "fine".   She had a dental appointment planned that she had to cancel, she has moved it to May 4th.
Severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (Severe diarrhea). At the time of the report, DIARRHOEA (Severe diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication include Imodium chloride.